Consolidated Statement of Operations - USD ($)	3 Months Ended
	Jan. 31, 2020	Jan. 31, 2019
Details
Revenues	$ 4,225,315	$ 3,656,124
Operating expenses:
Cost of revenues	2,286,066	2,032,420
Research and development expenses	112,303	143,955
Selling, general, and administrative expenses	2,168,350	2,245,897
Operating Expenses	4,566,719	4,422,272
Loss from operations	(341,404)	(766,148)
Interest expense - related party	210,286	167,919
Loss before income taxes	(551,690)	(934,067)
Provision for income taxes	31,560	0
Net loss	$ (583,250)	$ (934,067)
Net loss per common share - basic	$ (0.08)	$ (0.12)
Net loss per common share - diluted	$ (0.08)	$ (0.12)
Weighted average number of common shares outstanding - basic	7,706,004	7,696,091
Weighted average number of common shares outstanding - diluted	7,706,004	7,696,091